{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:47:15Z","timestamp":1790628435229,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"Medical University of Silesia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.pharep.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T13:10:04Z","timestamp":1538572204000},"page":"175-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Exenatide modulates expression of metalloproteinases and their tissue inhibitors in TNF-\u03b1 stimulated human retinal pigment epithelial cells"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5343-1205","authenticated-orcid":false,"given":"Wojciech","family":"Garczorz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-6464","authenticated-orcid":false,"given":"Enrique","family":"Gallego-Colon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6767-9586","authenticated-orcid":false,"given":"Agnieszka","family":"Kosowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Siemianowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"K\u0142ych-Ratuszny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Wo\u017aniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6284-2399","authenticated-orcid":false,"given":"Mohammad Reza F.","family":"Aghdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6321-6090","authenticated-orcid":false,"given":"Tomasz","family":"Francuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Dorecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2018.10.003_bib0005","unstructured":"Nam H. Cho editor. IDF Diabetes Atlas, 8th edition. Brussels, Belgium: International Diabetes Federation, 2017."},{"key":"10.1016\/j.pharep.2018.10.003_bib0010","series-title":"Global report on diabetes","year":"2016"},{"issue":"March(3)","key":"10.1016\/j.pharep.2018.10.003_bib0015","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"May(4)","key":"10.1016\/j.pharep.2018.10.003_bib0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ceo.12696","article-title":"Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review","volume":"44","author":"Ting","year":"2016","journal-title":"Clin Experiment Ophthalmol"},{"issue":"September(14)","key":"10.1016\/j.pharep.2018.10.003_bib0025","first-page":"977","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"issue":"9131","key":"10.1016\/j.pharep.2018.10.003_bib0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"October(19)","key":"10.1016\/j.pharep.2018.10.003_bib0035","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/archinte.1994.00420190068008","article-title":"Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy","volume":"154","author":"Klein","year":"1994","journal-title":"Arch Intern Med"},{"issue":"March(2)","key":"10.1016\/j.pharep.2018.10.003_bib0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00002512-199609020-00001","article-title":"Role of the Maillard Reaction in Diabetes Mellitus and Diseases of Aging","volume":"9","author":"Thorpe","year":"1996","journal-title":"Drugs Aging"},{"issue":"March(2)","key":"10.1016\/j.pharep.2018.10.003_bib0045","doi-asserted-by":"crossref","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","article-title":"Diabetic retinopathy","volume":"17","author":"Wong","year":"2016","journal-title":"Nat Rev Dis Prim."},{"key":"10.1016\/j.pharep.2018.10.003_bib0050","first-page":"1","article-title":"Retinal pigment epithelial cells express a functional receptor for glucagon-like Peptide-1 (GLP-1)","volume":"2013","author":"Puddu","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.pharep.2018.10.003_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/190724","article-title":"The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier\u2014implications for the pathogenesis of diabetic retinopathy","volume":"2010","author":"Sim\u00f3","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"July(3)","key":"10.1016\/j.pharep.2018.10.003_bib0060","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1152\/physrev.00021.2004","article-title":"The retinal pigment epithelium in visual function","volume":"85","author":"Strauss","year":"2005","journal-title":"Physiol Rev"},{"issue":"August(1)","key":"10.1016\/j.pharep.2018.10.003_bib0065","doi-asserted-by":"crossref","first-page":"20639","DOI":"10.1038\/srep20639","article-title":"Impairing autophagy in retinal pigment epithelium leads to inflammasome activation and enhanced macrophage-mediated angiogenesis","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharep.2018.10.003_bib0070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cyto.2017.02.013","article-title":"Retinal pigment epithelium-secretome: A diabetic retinopathy perspective","volume":"95","author":"Ponnalagu","year":"2017","journal-title":"Cytokine"},{"issue":"August(5)","key":"10.1016\/j.pharep.2018.10.003_bib0075","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1167\/iovs.10-6518","article-title":"Significance of outer blood\u2013Retina barrier breakdown in diabetes and ischemia","volume":"52","author":"Xu","year":"2011","journal-title":"Investig Opthalmol Vis Sci"},{"key":"10.1016\/j.pharep.2018.10.003_bib0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.visres.2017.02.006","article-title":"Effects of diabetic retinopathy on the barrier functions of the retinal pigment epithelium","volume":"139","author":"Xia","year":"2017","journal-title":"Vision Res"},{"issue":"September(3)","key":"10.1016\/j.pharep.2018.10.003_bib0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/exer.1997.0341","article-title":"Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-\u03b2-induced RPE cell apoptosis","volume":"65","author":"Esser","year":"1997","journal-title":"Exp Eye Res"},{"issue":"May(6)","key":"10.1016\/j.pharep.2018.10.003_bib0090","article-title":"Local and systemic inflammatory biomarkers of diabetic retinopathy: an integrative approach","volume":"58","author":"Vujosevic","year":"2017","journal-title":"Investig Opthalmol Vis Sci"},{"issue":"October(8)","key":"10.1016\/j.pharep.2018.10.003_bib0095","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2174\/1570159X14666160614095559","article-title":"Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss","volume":"14","author":"Kad\u0142ubowska","year":"2016","journal-title":"Curr Neuropharmacol"},{"issue":"June(2)","key":"10.1016\/j.pharep.2018.10.003_bib0100","article-title":"Current concepts regarding developmental mechanisms in diabetic retinopathy in Taiwan","volume":"6","author":"Chen","year":"2016","journal-title":"BioMedicine"},{"issue":"January(1)","key":"10.1016\/j.pharep.2018.10.003_bib0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim Biophys Acta - Mol Cell Res."},{"issue":"11","key":"10.1016\/j.pharep.2018.10.003_bib0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/gb-2011-12-11-233","article-title":"Tissue inhibitors of metalloproteinases","volume":"12","author":"Murphy","year":"2011","journal-title":"Genome Biol"},{"issue":"January(1)","key":"10.1016\/j.pharep.2018.10.003_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2009.08.003","article-title":"The dynamic nature of Bruch\u2019s membrane","volume":"29","author":"Booij","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"January(1)","key":"10.1016\/j.pharep.2018.10.003_bib0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbamcr.2009.09.017","article-title":"Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions","volume":"1803","author":"Deryugina","year":"2010","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"issue":"August(8)","key":"10.1016\/j.pharep.2018.10.003_bib0125","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1167\/iovs.04-1489","article-title":"Pigment Epithelium\u2013Derived Factor Is a Substrate for Matrix Metalloproteinase Type 2 and Type 9: Implications for Downregulation in Hypoxia","volume":"46","author":"Notari","year":"2005","journal-title":"Investig Opthalmol Vis Sci"},{"issue":"July(1)","key":"10.1016\/j.pharep.2018.10.003_bib0130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2012.03.025","article-title":"Opticin production is reduced by hypoxia and VEGF in human retinal pigment epithelium via MMP-2 activation","volume":"59","author":"Ma","year":"2012","journal-title":"Cytokine"},{"issue":"June(14)","key":"10.1016\/j.pharep.2018.10.003_bib0135","first-page":"1114","article-title":"Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy","volume":"14","author":"Ber\u00e1nek","year":"2008","journal-title":"Mol Vis"},{"issue":"March(1)","key":"10.1016\/j.pharep.2018.10.003_bib0140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1196\/annals.1394.000","article-title":"Matrix Metalloproteinase-2 Expression and Apoptogenic Activity in Retinal Pericytes: Implications in Diabetic Retinopathy","volume":"1103","author":"Yang","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"April(1)","key":"10.1016\/j.pharep.2018.10.003_bib0145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.diabres.2009.01.012","article-title":"Proliferative diabetic retinopathy\u2014The influence of diabetes control on the activation of the intraocular molecule system","volume":"84","author":"Adamiec-Mroczek","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"December(12)","key":"10.1016\/j.pharep.2018.10.003_bib0150","article-title":"Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy. Tsilibary EC, editor","volume":"8","author":"Abu El-Asrar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharep.2018.10.003_bib0155","first-page":"921","article-title":"Interleukin-4 and melatonin ameliorate high glucose and interleukin-1\u03b2 stimulated inflammatory reaction in human retinal endothelial cells and retinal pigment epithelial cells","volume":"20","author":"Xie","year":"2014","journal-title":"Mol Vis"},{"issue":"December(4)","key":"10.1016\/j.pharep.2018.10.003_bib0160","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/pr.108.000604","article-title":"The role of incretins in glucose homeostasis and diabetes treatment","volume":"60","author":"Kim","year":"2008","journal-title":"Pharmacol Rev"},{"issue":"March(3)","key":"10.1016\/j.pharep.2018.10.003_bib0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/modpathol.2014.113","article-title":"Glucagon-like-peptide-1 receptor expression in normal and diseased human thyroid and pancreas","volume":"28","author":"Waser","year":"2015","journal-title":"Mod Pathol"},{"issue":"Suppl. 1","key":"10.1016\/j.pharep.2018.10.003_bib0170","first-page":"S52","article-title":"Approaches to glycemic treatment","volume":"39","author":"Cefalu","year":"2016","journal-title":"Diabetes Care"},{"issue":"March(3)","key":"10.1016\/j.pharep.2018.10.003_bib0175","article-title":"A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond","volume":"4","author":"Prasad-Reddy","year":"2015","journal-title":"Drugs Context"},{"issue":"February(1)","key":"10.1016\/j.pharep.2018.10.003_bib0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pharep.2014.08.007","article-title":"Effects of incretin agonists on endothelial nitric oxide synthase expression and nitric oxide synthesis in human coronary artery endothelial cells exposed to TNF\u03b1 and glycated albumin","volume":"67","author":"Garczorz","year":"2015","journal-title":"Pharmacol Rep"},{"issue":"April(2)","key":"10.1016\/j.pharep.2018.10.003_bib0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/2042018814543483","article-title":"Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis","volume":"5","author":"Al-Badri","year":"2014","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.pharep.2018.10.003_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/538737","article-title":"Sitagliptin Prevents Inflammation and Apoptotic Cell Death in the Kidney of Type 2 Diabetic Animals","volume":"2014","author":"Marques","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.pharep.2018.10.003_bib0195","first-page":"1","article-title":"Anti-inflammatory effects of GLP-1-Based therapies beyond glucose control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10.1016\/j.pharep.2018.10.003_bib0200","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S1734-1140(13)71069-7","article-title":"Exendin-4 and GLP-1 decreases induced expression of ICAM-1, VCAM-1 and RAGE in human retinal pigment epithelial cells","volume":"65","author":"Dorecka","year":"2013","journal-title":"Pharmacol Rep"},{"issue":"March(5)","key":"10.1016\/j.pharep.2018.10.003_bib0205","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2337\/diabetes.52.5.1229","article-title":"Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats","volume":"52","author":"Roy","year":"2003","journal-title":"Diabetes"},{"issue":"August(8)","key":"10.1016\/j.pharep.2018.10.003_bib0210","first-page":"1308","article-title":"Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology","volume":"10","author":"Singh","year":"2017","journal-title":"Int J Ophthalmol"},{"issue":"September(9)","key":"10.1016\/j.pharep.2018.10.003_bib0215","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.bbadis.2014.04.013","article-title":"Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats","volume":"1842","author":"Gon\u00e7alves","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharep.2018.10.003_bib0220","first-page":"1","article-title":"Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes","author":"Hern\u00e1ndez","year":"2017","journal-title":"Diabetologia"},{"issue":"March(3)","key":"10.1016\/j.pharep.2018.10.003_bib0225","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pharmthera.2006.11.007","article-title":"Mechanisms of action of glucagon-like peptide 1 in the pancreas","volume":"113","author":"Doyle","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"June(12)","key":"10.1016\/j.pharep.2018.10.003_bib0230","doi-asserted-by":"crossref","first-page":"E1453","DOI":"10.1152\/ajpendo.00660.2011","article-title":"Role of PRAS40 in Akt and mTOR signaling in health and disease","volume":"302","author":"Wiza","year":"2012","journal-title":"AJP Endocrinol Metab"},{"issue":"May(6)","key":"10.1016\/j.pharep.2018.10.003_bib0235","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1167\/iovs.10-6368","article-title":"Novel role of mitochondrial matrix Metalloproteinase-2 in the development of diabetic retinopathy","volume":"52","author":"Mohammad","year":"2011","journal-title":"Investig Opthalmol Vis Sci"},{"issue":"April(4)","key":"10.1016\/j.pharep.2018.10.003_bib0240","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.iae.0000238549.74626.33","article-title":"MMP-2 and MMP-9 secretion by rpe is stimulated by angiogenic molecules found in choroidal neovascular membranes","volume":"26","author":"Hoffmann","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.pharep.2018.10.003_bib0245","article-title":"Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"27","author":"Dicembrini","year":"2017","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.pharep.2018.10.003_bib0250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbrc.2012.07.044","article-title":"TNF-\u03b1 promotes human retinal pigment epithelial (RPE) cell migration by inducing matrix metallopeptidase 9 (MMP-9) expression through activation of Akt\/mTORC1 signaling","volume":"425","author":"hu","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"October(4)","key":"10.1016\/j.pharep.2018.10.003_bib0255","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/mus.20383","article-title":"Regulation of TIMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation","volume":"32","author":"Lluri","year":"2005","journal-title":"Muscle Nerve"},{"issue":"July(7)","key":"10.1016\/j.pharep.2018.10.003_bib0260","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.2337\/db10-0110","article-title":"Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy","volume":"59","author":"Schwartzman","year":"2010","journal-title":"Diabetes"},{"issue":"January(1)","key":"10.1016\/j.pharep.2018.10.003_bib0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajpath.2011.09.008","article-title":"An alternate perspective on the roles of TIMPs and MMPs in pathology","volume":"180","author":"Moore","year":"2012","journal-title":"Am J Pathol"},{"issue":"September(9)","key":"10.1016\/j.pharep.2018.10.003_bib0270","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00210-015-1124-3","article-title":"Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes\/macrophages","volume":"388","author":"Bu\u0142dak","year":"2015","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"June(12)","key":"10.1016\/j.pharep.2018.10.003_bib0275","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.freeradbiomed.2009.03.024","article-title":"Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2","volume":"46","author":"Kowluru","year":"2009","journal-title":"Free Radic Biol Med"},{"issue":"May(5)","key":"10.1016\/j.pharep.2018.10.003_bib0280","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1167\/iovs.02-0662","article-title":"Production and activation of matrix Metalloproteinase-2 in proliferative diabetic retinopathy","volume":"44","author":"Noda","year":"2003","journal-title":"Investig Opthalmol Vis Sci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018301701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018301701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:47Z","timestamp":1752611867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.10.003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1734114018301701"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.10.003","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exenatide modulates expression of metalloproteinases and their tissue inhibitors in TNF-\u03b1 stimulated human retinal pigment epithelial cells","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}